Stay updated on NAC Efficacy in Preventing Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the NAC Efficacy in Preventing Severe COVID-19 Clinical Trial page.

Latest updates to the NAC Efficacy in Preventing Severe COVID-19 Clinical Trial page
- Check3 days agoChange DetectedThe temporary NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” terminology is no longer displayed. The study page still shows a 403 Forbidden error.SummaryDifference1%

- Check10 days agoChange DetectedThe page now displays the ClinicalTrials.gov site shell instead of a 403 Forbidden response, and the site revision is updated from v3.7.2 to v3.8.0. No study-result content is shown.SummaryDifference0.6%

- Check16 days agoChange DetectedA banner announces NIH’s website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe results view now displays a 403 Forbidden message, replacing the previous results content and indicating that access to the study's results is blocked on this page.SummaryDifference6%

Stay in the know with updates to NAC Efficacy in Preventing Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NAC Efficacy in Preventing Severe COVID-19 Clinical Trial page.